ArticleClinics (Sao Paulo, Brazil)2024
Analysis of PD-1/PD-L1 variations in lung cancer and association with immunotherapeutic efficacy and prognosis: A nonrandomized controlled trial.
Jun Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.